EUVIMEDEUVIMED entdecken
Beobachtungsstudie

Characteristics and prognostic value of pre-treatment 18F-FDG PET in neuroblastoma

Wenzhu Hu, Baicheng Qu, Yangmeihui Song, Mengting Li, Chunxia Qin, Xiaoli Lan iD

European Journal of Nuclear Medicine and Molecular Imaging · 2026

DOI: 10.1007/s00259-026-07977-1 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift European Journal of Nuclear Medicine and Molecular Imaging, 2026. Verfasst von Wenzhu Hu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, No. 1277 Jiefang Ave, Wuhan, 4…. Hauptthemen laut MEDLINE: Fluorodeoxyglucose F18, Neuroblastoma, Positron-Emission Tomography. Die Arbeit nennt 37 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Hubei Province Science and Technology Innovation Team.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: This study aimed to evaluate the imaging features and prognostic value of metabolic parameters derived from pretreatment 18F-FDG PET in pediatric neuroblastoma (NB) patients, and to establish a prognostic prediction model. METHODS: This retrospective analysis included pediatric patients with extracranial embryonic solid tumours, notably NB, who underwent pretreatment 18F-FDG PET between Jan 2013 and Sep 2023 (NCT06190574). PET parameters were recorded, including SUVmax, SUVmean and their liver-normalized ratios (SUVmax/liver, SUVmean/liver), TLG, MTV. The diagnostic value of 18F-FDG PET for distinguishing NB were calculated. Correlations between metabolic parameters and clinical variables (age, gender, NSE, LDH, ferritin, INSS, and INRGSS stages) were analyzed. Survival analysis using the Kaplan-Meier method was performed to identify predictors of PFS and OS. A nomogram incorporating variables selected by univariate COX and LASSO regression was created, with its discrimination and calibration assessed. RESULTS: Among 81 patients, 41 were pathologically confirmed as NB, yielding an 18F-FDG PET sensitivity of 92.7% and specificity of 95.0%. Metastasis was associated with all serological markers and PET parameters. TLG and MTV correlated with NSE and LDH. Of the confirmed NB patients, 37 were eligible for inclusion in survival analysis. PFS was associated with age, maximum diameter, SUVmax, TLG, MTV, ferritin, NSE and LDH. OS was significantly influenced by age, maximum diameter, SUVmax, SUVmean SUVmax/liver, SUVmean/liver, TLG, MTV, NSE, LDH. The prognostic model incorporating maximum diameter, MTV and NSE exhibited favorable discrimination and calibration. CONCLUSION: 18F-FDG PET provides valuable diagnostic and prognostic information for NB. The proposed nomogram integrating maximum diameter, MTV, and NSE serves as a practical tool for assessing patient condition and predicting survival outcomes. TRIAL REGISTRATION: NCT06190574.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fluorodeoxyglucose F18NeuroblastomaPositron-Emission TomographyChildChild, PreschoolFemaleHumansInfantMalePrognosisRadiopharmaceuticalsRetrospective Studies

Stichwörter der Autor:innen

18F-FDGNeuroblastomaPETPrognosis

Substanzen

Fluorodeoxyglucose F18Radiopharmaceuticals

Autor:innen und Institutionen

  • Department of Nuclear Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, No. 1277 Jiefang Ave, Wuhan, 430022, Hubei Province, China.
  • Hubei Key Laboratory of Molecular Imaging, Wuhan, China.
  • Key Laboratory of Biological Targeted Therapy, the Ministry of Education, Wuhan, China.
  • Department of Nuclear Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, No. 1277 Jiefang Ave, Wuhan, 430022, Hubei Province, China. limengtingtjmu@163.com.
  • Hubei Key Laboratory of Molecular Imaging, Wuhan, China. limengtingtjmu@163.com.
  • Key Laboratory of Biological Targeted Therapy, the Ministry of Education, Wuhan, China. limengtingtjmu@163.com.

ORCID-Profile: Xiaoli Lan

Förderung

  • National Natural Science Foundation of China
  • Hubei Province Science and Technology Innovation Team

Zitieren

APA

Hu, W., Qu, B., Song, Y., Li, M., Qin, C., & Lan, X. (2026). Characteristics and prognostic value of pre-treatment 18F-FDG PET in neuroblastoma. European Journal of Nuclear Medicine and Molecular Imaging. https://doi.org/10.1007/s00259-026-07977-1

Vancouver

Hu W, Qu B, Song Y, Li M, Qin C, Lan X. Characteristics and prognostic value of pre-treatment 18F-FDG PET in neuroblastoma. European Journal of Nuclear Medicine and Molecular Imaging. 2026. doi:10.1007/s00259-026-07977-1

BibTeX
@article{Hu2026,
  author = {Hu, Wenzhu and Qu, Baicheng and Song, Yangmeihui and Li, Mengting and Qin, Chunxia and Lan, Xiaoli},
  title = {Characteristics and prognostic value of pre-treatment 18F-FDG PET in neuroblastoma},
  journal = {European Journal of Nuclear Medicine and Molecular Imaging},
  year = {2026},
  doi = {10.1007/s00259-026-07977-1}
}
Kostenlos starten →